NEOVA® Launches DNA Repair-Based Treatment Sunscreens

MONTGOMERYVILLE, Pa., May 5, 2011 /PRNewswire/ -- PhotoMedex, Inc. (Nasdaq: PHMD) a leading supplier of advanced, clinical skincare and medical laser products, today introduced DNA Damage Control, the breakthrough treatment sunscreens that feature advanced photoprotection with DNA repair technology.

Formulated by and marketed under the company’s NEOVA® brand, the DNA Damage Control sunscreens offer an unrivaled repair and protect system that defends against photodamage insults with a new and powerful therapy: boosting the body's natural DNA repair process.  The patent-pending formulas use liposomes to deliver DNA repair enzymes to the cellular level of the skin, hyper-targeting the site of the DNA injury.

In clinical studies, DNA repair enzymes were shown to reduce DNA damage by 45% and increase UV protection by 300% – in just one hour.(1)

"Photodamage occurs every day, even on cloudy days, and damage to our skin is cumulative. Even if you don't see a sunburn, sun exposure can lead to wrinkles, pigmentation changes and more serious consequences including skin cancer," said Melanie Grossman, MD, New York-based dermatologist. "The NEOVA sunscreens offer broadband photoprotection and deliver both antioxidants and DNA repair enzymes which combine for advanced sun protection."

Drawing upon more than 20 years DNA-based research by leading molecular biologists, the DNA Damage Control sunscreens feature two patented DNA repair enzymes – photolysomes and endosomes.  These liposome-encapsulated enzymes work with potent antioxidants to defend cells and accelerate the body's ability to repair solar DNA damage. The elegant formulas feature both physical and chemical barriers for thorough broad-spectrum UV protection.

DNA Damage Control Everyday SPF 43

The lightweight, oil-free moisturizing formula is designed especially for daily photoprotection of the face, neck, decolletage and back of hands. It enhances the skin's natural daily repair system to heal previous sun-induced damage, and provide unrivaled broad spectrum protection, which stops photodamage from occurring.

DNA Damage Control Active SPF 45

Ideal for year-round, active, outdoor lifestyles, this highly water-resistant formula for the face and body repairs while it protects and accelerates recovery from sun-induced damage.

DNA Damage Control Sheer SPF 45 Photo Finish Tint

A micronized physical sunscreen with sheer tint for the face, evens out skin tone. Perfect alone or as an under-makeup primer.

NEOVA® DNA Damage Control Active SPF 43, DNA Damage Control Everyday SPF 45 and DNA Damage Control Sheer Tint SPF 45 sunscreens are available through dispensing physicians and on www.NextDerm.com.

(1)Stege H, Roza L, Vink AA, et al. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci. 2000; 97(4)

About PhotoMedex

PhotoMedex is a leader in the development, manufacturing, and global marketing of dermatology products and techniques focused on advancing cost-effective technologies that provide patients with better outcomes and a higher quality of life. The Company is uniquely positioned to research and commercialize therapies that innovatively combine both medical devices and specialty pharmaceutical products. Medical Devices include the XTRAC® Excimer Laser for the treatment of skin diseases, including psoriasis and vitiligo, and the Omnilux™ non-laser Light Emitting Diodes (LED) for the treatment of clinical and aesthetic dermatological conditions including acne, photodamage, skin rejuvenation, wound healing, and non-melanoma skin cancer. Adding to these therapies, the Company markets a broad range of specialty pharmaceutical products based upon its patented, clinically proven Copper Peptide technology for skin health, hair care, and wound care including its ProCyte brands of NEOVA®, DNA Damage Control, Tricomin® and Graftcyte®. PhotoMedex sells directly to dermatologists, plastic and cosmetic surgeons, spas, salons, and through licenses with strategic partners in the consumer market. In addition, the Company manufactures and distributes surgical lasers and disposables to hospitals and surgery centers for procedures in multiple other surgical specialties.

SOURCE PhotoMedex, Inc.